| 1 | MCQUILLAN, ROBERTTILGHMAN, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2025-06-28 | $2,000 | Primary 2026 (P2026) | EARMARK VIA ACTBLUE ON 2025-06-29Filing 1902809Original filing ↗ |
| 2 | MCQUILLAN, ROBERT5, BAY HUNDRED, MD · 21671 | SALES · PHARMAVITE | ACTBLUEC00401224 | 2025-06-28 | $2,000 | Not reported | EARMARKED FOR DAN SCHWARTZ FOR CONGRESS (C00902957)Filing 1909062Original filing ↗ |
| 3 | MCQUILLAN, ROBERTTILGHMAN, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2025-04-19 | $1,000 | Primary 2026 (P2026) | EARMARK VIA ACTBLUE ON 2025-04-27Filing 1902809Original filing ↗ |
| 4 | MCQUILLAN, ROBERTTILGHMAN, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2025-06-30 | $500 | Primary 2026 (P2026) | EARMARK VIA ACTBLUE ON 2025-06-30Filing 1902809Original filing ↗ |
| 5 | MILLS, MICHAELFAYETTEVILLE, NC · 28312 | REVERSE LOGISTICS · PHARMAVITE | NORTH CAROLINA REPUBLICAN PARTYC00038505 | 2025-11-03 | $258 | Primary (P) | Filing 1930653 · amendedOriginal filing ↗ |
| 6 | MCQUILLAN, ROBERTTILGHMAN ISLAND, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2026-06-17 | $100Memo only · not additional money | General 2026 (G2026) | REDESIGNATION TOFiling 1996237Original filing ↗ |
| 7 | MCQUILLAN, ROBERTTILGHMAN ISLAND, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2026-06-17 | $100 | Primary 2026 (P2026) | EARMARK VIA ACTBLUE ON 2026-06-21Filing 1996237Original filing ↗ |
| 8 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-04-17 | $66 | Primary 2026 (P2026) | Filing 1902035Original filing ↗ |
| 9 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-07-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1920441Original filing ↗ |
| 10 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-12-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014Original filing ↗ |
| 11 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-05-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1902035Original filing ↗ |
| 12 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-08-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1920441Original filing ↗ |
| 13 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-11-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014Original filing ↗ |
| 14 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-09-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1920441Original filing ↗ |
| 15 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-06-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1902035Original filing ↗ |
| 16 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-10-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014Original filing ↗ |
| 17 | WHITE, BRYANSAN DIEGO, CA · 92104 | BRAND MANAGEMENT · PHARMAVITE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-04-04 | $50 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1902035Original filing ↗ |
| 18 | MCQUILLAN, ROBERTTILGHMAN ISLAND, MD · 21671 | SALES PROFESSIONAL · PHARMAVITE | DAN SCHWARTZ FOR CONGRESSC00902957 | 2026-06-17 | -$100Memo only · not additional money | Primary 2026 (P2026) | REDESIGNATION FROMFiling 1996237Original filing ↗ |